Benitec Biopharma Limited Sponsored ADR
(NASDAQ : BNTC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.15%197.151.2%$609.08m
GILDGilead Sciences, Inc.
-0.06%67.970.9%$502.92m
CELGCelgene Corporation
-2.90%67.391.2%$479.05m
BIIBBiogen Inc.
0.64%321.251.3%$470.59m
ILMNIllumina, Inc.
0.02%301.663.5%$381.79m
REGNRegeneron Pharmaceuticals, Inc.
0.16%339.542.6%$299.15m
VRTXVertex Pharmaceuticals Incorporated
-0.58%160.141.9%$259.04m
ALXNAlexion Pharmaceuticals, Inc.
1.83%117.172.0%$202.73m
AAgilent Technologies, Inc.
7.73%67.451.5%$200.36m
SRPTSarepta Therapeutics, Inc.
1.73%118.3715.4%$149.30m
LGNDLigand Pharmaceuticals Incorporated
1.86%151.3023.3%$142.17m
EXASExact Sciences Corporation
-3.52%64.9125.3%$132.19m
TSROTESARO, Inc.
18.18%43.5314.4%$129.29m
NKTRNektar Therapeutics
0.50%38.205.6%$122.85m
INCYIncyte Corporation
-0.73%63.782.5%$114.89m

Company Profile

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. It operates through the Australia, and United States of America geographical segments. The company was founded in 1997 and is headquartered in North Sydney, Australia.